2020
DOI: 10.1039/d0tb00987c
|View full text |Cite
|
Sign up to set email alerts
|

Advances in local and systemic drug delivery systems for post-surgical cancer treatment

Abstract: Surgery is considered to be the favored approach for the treatment of most of the solid tumor malignancies. The quality of life among cancer patients has significantly improved due to...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
20
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(20 citation statements)
references
References 108 publications
0
20
0
Order By: Relevance
“…Local drug delivery offers dramatically higher drug concentrations in tumor tissues, while reducing harmful side effects to healthy organs and minimizing local tumor relapse [ 2 ]. Locoregional cancer treatment relies on the implementation of drug delivery vehicles for cancerous lesions.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Local drug delivery offers dramatically higher drug concentrations in tumor tissues, while reducing harmful side effects to healthy organs and minimizing local tumor relapse [ 2 ]. Locoregional cancer treatment relies on the implementation of drug delivery vehicles for cancerous lesions.…”
Section: Introductionmentioning
confidence: 99%
“…This strategy involves synthetic or natural polymer-based foams, wafers, fiber mats, and scaffolds. In this approach, mostly biodegradable matrices are proposed to avoid additional surgery for the removal of the biomaterial and to prevent a chronic immune response against foreign bodies [ 2 ]. Systemic drug delivery relies on nanomaterial-based DDSs, such as liposomes, micelles, dendrimers, and nanoparticles (NPs) that deliver therapeutic agents to cancer [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Targeted drug delivery has received much interest in recent years, particularly for cancer treatment where it has the potential to not only improve the effectiveness of chemotherapy but also to minimize side effects and complications caused by indiscriminate exposure of healthy regions [ 25 ]. Highly targeted local administration of drugs, such as via intratumoral injection, therefore, has been actively studied as a solution to overcome such limitations [ 26 , 27 ]. Although intratumoral injections of drugs are feasible for various cancers and target organs, lack of controllability of drug transport to the target site (e.g.…”
Section: Introductionmentioning
confidence: 99%
“…For patients with different types of solid tumors, the most commonly used first‐line clinical treatment is combination of surgery and chemotherapy. However, one of the main problems of chemotherapy is the extremely low bioavailability of anti‐tumor drugs and adverse side effects 4–6 . Many nano‐platforms such as micelles, liposomes, vesicles and nanoparticles have been designed to prevent drug deterioration while increasing effective drug concentration at lesion site 7–10 .…”
Section: Introductionmentioning
confidence: 99%
“…However, one of the main problems of chemotherapy is the extremely low bioavailability of anti-tumor drugs and adverse side effects. [4][5][6] Many nano-platforms such as micelles, liposomes, vesicles and nanoparticles have been designed to prevent drug deterioration while increasing effective drug concentration at lesion site. [7][8][9][10] Among them, micelles have attracted much interest due to their advantageous characteristics, including good stability in vivo, long circulation in the bloodstream, sustained and adjustable drug release performance.…”
mentioning
confidence: 99%